We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $5.3M
1-Year Est. Return 7.8%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+7.8%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
Cap. Flow
+$23.3M
Cap. Flow %
11.78%
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396

Top Buys

Rank Stock Value
1
DK icon
Delek US
DK
+$871K
2
AVGO icon
Broadcom
AVGO
+$691K
3
A icon
Agilent Technologies
A
+$650K
4
TLS icon
Telos
TLS
+$640K
5
PGY icon
Pagaya Technologies
PGY
+$627K

Top Sells

Rank Stock Value
1
ARRY icon
Array Technologies
ARRY
+$730K
2
VRT icon
Vertiv
VRT
+$639K
3
ZVRA icon
Zevra Therapeutics
ZVRA
+$635K
4
BOW
Bowhead Specialty Holdings
BOW
+$608K
5
RIGL icon
Rigel Pharmaceuticals
RIGL
+$581K

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Industrials 15.16%
3 Financials 12.4%
4 Consumer Discretionary 11.79%
5 Healthcare 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TIMB icon
526
TIM SA
TIMB
$8.98B
$208K 0.11%
+10,683
New +$235K
FNB icon
527
FNB Corp
FNB
$6.38B
$208K 0.11%
+12,149
New +$199K
GTLB icon
528
GitLab
GTLB
$8.2B
$208K 0.11%
+5,535
New +$240K
SAIA icon
529
Saia
SAIA
$9.1B
$208K 0.11%
+636
New +$192K
ZIP icon
530
ZipRecruiter
ZIP
$304M
$208K 0.11%
53,238
+674
+1% +$3.03K
OHI icon
531
Omega Healthcare
OHI
$14.1B
$207K 0.1%
4,667
-4,489
-49% -$193K
ANIK icon
532
Anika Therapeutics
ANIK
$278M
$207K 0.1%
21,524
-19,862
-48% -$190K
FORM icon
533
FormFactor
FORM
$9.25B
$206K 0.1%
+3,701
New +$186K
XRX icon
534
Xerox
XRX
$449M
$206K 0.1%
87,018
+40,194
+86% +$119K
GRAB icon
535
Grab
GRAB
$11.4B
$206K 0.1%
+41,287
New +$228K
MLI icon
536
Mueller Industries
MLI
$13.3B
$206K 0.1%
3,582
-1,850
-34% -$99.5K
CUK
537
DELISTED
Carnival PLC
CUK
$206K 0.1%
+6,778
New +$175K
UPBD icon
538
Upbound Group
UPBD
$999M
$205K 0.1%
+11,678
New +$226K
AEP icon
539
American Electric Power
AEP
$65.3B
$205K 0.1%
1,775
-1,169
-40% -$138K
U icon
540
Unity
U
$18.2B
$204K 0.1%
+4,625
New +$188K
WOLF icon
541
Wolfspeed
WOLF
$1.35B
$204K 0.1%
+11,723
New +$269K
EQH icon
542
Equitable Holdings
EQH
$14.7B
$204K 0.1%
+4,279
New +$203K
KFRC icon
543
Kforce
KFRC
$929M
$204K 0.1%
+6,590
New +$194K
EEFT icon
544
Euronet Worldwide
EEFT
$2.47B
$204K 0.1%
2,677
-4,052
-60% -$316K
CASY icon
545
Casey's General Stores
CASY
$22.1B
$203K 0.1%
368
-44
-11% -$24.2K
ACIC icon
546
American Coastal Insurance
ACIC
$434M
$203K 0.1%
16,091
-20,796
-56% -$251K
CASS icon
547
Cass Information Systems
CASS
$701M
$203K 0.1%
+4,891
New +$199K
BMY icon
548
Bristol-Myers Squibb
BMY
$129B
$203K 0.1%
3,762
-2,596
-41% -$125K
SENEA icon
549
Seneca Foods Class A
SENEA
$1.25B
$203K 0.1%
1,834
-1,454
-44% -$166K
CLF icon
550
Cleveland-Cliffs
CLF
$7.13B
$202K 0.1%
+15,227
New +$192K
20 21
22
23 24

Similar funds

SA
SPG Advisors Kirkland, Washington $5.55M AUM 9.46% 1-Year Est. Return
BP
Berkshire Partners Boston, Massachusetts $4.96M AUM 59.38% 1-Year Est. Return
WI
Wafra Inc New York $5.88M AUM 19.88% 1-Year Est. Return
LAM
Longboard Asset Management Phoenix, Arizona $5.96M AUM 32.27% 1-Year Est. Return
PFGWM
Price Financial Group Wealth Management Portland, Oregon $6.02M AUM
BM
Belfer Management New York $6.03M AUM 13.97% 1-Year Est. Return
OFC
Oakland Financial Corp $4.51M AUM 54.36% 1-Year Est. Return
AL
ACME LLC San Francisco, California $6.23M AUM 17.76% 1-Year Est. Return

PharVision Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.

  • PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
  • PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
  • PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
  • PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
  • PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
  • PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
  • PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.